Schering-Plough 1Q Revenues: $4.7 billion (+56%) 1Q Earnings: $291 million (-48%; earnings were $565 million in 1Q07) Comments: Global Pharmaceutical sales totaled $3.6 billion, which includes $1.3 billion of Organon Biosciences revenues. Sales of Remicade were up 36% to $507 million. Nasonex sales were $307 million (+8%); sales of Temodar were $236 million (+20%); Pegintron sales were $225 million (+4%); sales of Claritin (international only) were $128 million (+14%); sales of Avelox ...